NanoGuard Technologies is a cutting-edge technology company focused on revolutionizing sterilization of medical devices through its patented High Voltage Atmospheric Cold Plasma (HVACP) technology. Our technology provides a safer, faster, and economical alternative to traditional low-temperature sterilization methods, eliminating the risk of cancerous emissions associated with ethylene oxide.
Cold plasma, a partially ionized gas, is a powerful sterilization agent, generating reactive gas species that can destroy cellular DNA, reduce pathogen loads, and achieve medical-grade sterilization. Unlike traditional methods, which rely on high temperatures, toxic chemicals, or long exposure times, cold plasma operates at or near room temperature. Its reactive gas species revert back to air over time, leaving no harmful residues. This makes it an ideal alternative for industries facing increasingly stringent safety, environmental, and regulatory challenges, while eliminating the carcinogenic risks associated with ethylene oxide.
Unlike most cold plasma technologies, which treat directly within the plasma field, our indirect treatment approach allows for scalable and more efficient operations. Our plasma generator ionizes air, creating reactive gas species such as ozone, reactive oxygen, and reactive nitrogen, which possess antimicrobial properties. These charged gas particles then flow into a sterilization chamber, where they contact surfaces and effectively destroy pathogens.
Subscribe to our newsletter and be the first to receive updates on cutting-edge sterilization technologies,from NanoGuard Technologies.